Intravenous immunoglobulin for prophylaxis of neonatal sepsis in premature infants.
The incidence of sepsis, mortality due to sepsis, total mortality, and minor infections was evaluated in a group of 46 premature newborn infants who were treated with intravenous immunoglobulins. They were compared with an untreated control group. No significant differences were observed between the two groups.
Stabile
A
A
Department of Paediatrics, Catholic University, Rome, Italy.
Miceli Sopo
S
S
Romanelli
V
V
Pastore
M
M
Pesaresi
M A
MA
D001424:Bacterial Infections / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000032:analysis; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D008297:Male; D011897:Random Allocation
D007074:Immunoglobulin G